Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2026) 115 EP53 | DOI: 10.1530/endoabs.115.EP53

Academic Department of Endocrinology, Connolly Hospital Blanchardstown, Dublin, Ireland


Retinopathy and nephropathy are preventable microvascular complications of diabetes. National clinical guidelines suggest annual assessment of risk factors, including urinary Albumin-to-Creatinine Ratio (ACR) and retinal screening, to detect complications early and initiate appropriate treatments. A prospective audit of availability of ACR, currently measured off-site, and retina screening results was conducted over one month in the diabetes review clinics at Connolly Hospital. Additional data collected included demographics, prescription rates of additional therapies and patient awareness of associated sick day rules. Of 133 patient encounters, 75% were living with T2DM. Medication review indicated that 67% of patients were on either an ACEi or ARB; 42% were on an SGLT2i, but only 18% of these patients were aware of sick day rules. Laboratory records indicated 60% of patients had ACR samples received in laboratory of which only 18% had results available in clinic. Although 92% of patients reported being registered for diabetic retinopathy screening, only 16% had screening results accessible to the clinician. We identified substantial deficiencies in the availability of key clinical parameters with implications for treatment optimisation and adherence to clinical guidelines. The lack of real-time access to urine ACR and retinal screening results may hinder appropriate initiation or adjustment of therapies such as SGLT2i, ACEi/ARBs, and GLP-1 receptor agonists. We suggest a feasibility study is conducted in relation to on-site ACR testing with re-audit once this is in place.

Volume 115

Irish Endocrine Society Annual Meeting 2025

Portlaoise, Ireland
07 Nov 2025 - 08 Nov 2025

Irish Endocrine Society 

Browse other volumes

Article tools

My recent searches

No recent searches